Siren »

Taysha Gene Therapies shares owned by Siren

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Siren from 13F filings

Historical chart of Siren investment in Taysha Gene Therapies

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 2910M10.5M11M11.5M5M5.5M6M6.5M
Value ($)Share countHistorical TSHA position of Siren Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Siren

Quarter filed Position value Share count Share price at filing
2024-12-31 $11M 6.6M 1.73
2024-09-30 $9.8M 4.9M 2.01

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Beigene Sponsored Adr (ONC)
Kymera Therapeutics (KYMR)
Apellis Pharmaceuticals (APLS)
Crinetics Pharmaceuticals In (CRNX)
argenx SE Sponsored Adr (ARGX)
Bicara Therapeutics (BCAX)
Arrowhead Pharmaceuticals (ARWR)
NewAmsterdam Pharma Company NV Ordinary Shares (NAMS)
Septerna (SEPN)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Springworks Therapeutics (SWTX)
Neumora Therapeutics (NMRA)
WAVE Life Sciences SHS (WVE)
Ascendis Pharma A/S Sponsored Adr (ASND)

View all positions for Siren

Top funds holding Taysha Gene Therapies

venBio Select Advisor
Morgan Stanley
FMR
BlackRock
RA Capital Management
Octagon Capital Advisors
Vanguard Group
Rtw Investments
Siren
State Street Corporation
Adage Capital Partners GP
Baker Bros. Advisors
Tybourne Capital Management
Geode Capital Management
VR Adviser

View all funds holding Taysha Gene Therapies